Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle L Swaney

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Nature Communications|July 19, 2025
Plasma proteomics for biomarker discovery in childhood tuberculosisAndrea Fossati, Peter Wambi, Devan Jaganath, et al.
Clinical Proteomics|June 9, 2026
A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TBZaynab Mousavian, Mark R Segal, Roger I Calderon, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
A Multi-Omics Study Reveals Pathway-Level Insights and Predictive Biomarkers in pediatric TBZaynab Mousavian, Mark R Segal, Roger I Calderon, et al.
Nature|April 29, 2026
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPRNicole D Marino, Alexander Talaie, Milan Gerovac, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Plasma proteomics for novel biomarker discovery in childhood tuberculosisAndrea Fossati, Peter Wambi, Devan Jaganath, et al.
Research Square|August 6, 2025
Multicohort assessment of plasma metabolic signatures of tuberculosis disease in childrenMary M Nellis, Juaneta Luiz, Devan Jaganath, et al.
Aging Cell|September 18, 2022
Reduced endosomal microautophagy activity in aging associates with enhanced exocyst-mediated protein secretionGregory J Krause, Antonio Diaz, Maryam Jafari, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Mbio|February 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cellsUjjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar, et al.
The Journal of Clinical Investigation|November 15, 2021
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinomaNan Jin, Bhumsuk Keam, Janice Cho, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Nature Communications|July 19, 2025
Plasma proteomics for biomarker discovery in childhood tuberculosisAndrea Fossati, Peter Wambi, Devan Jaganath, et al.
Clinical Proteomics|June 9, 2026
A multi-omics study reveals pathway-level insights and predictive biomarkers in pediatric TBZaynab Mousavian, Mark R Segal, Roger I Calderon, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
A Multi-Omics Study Reveals Pathway-Level Insights and Predictive Biomarkers in pediatric TBZaynab Mousavian, Mark R Segal, Roger I Calderon, et al.
Nature|April 29, 2026
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPRNicole D Marino, Alexander Talaie, Milan Gerovac, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Plasma proteomics for novel biomarker discovery in childhood tuberculosisAndrea Fossati, Peter Wambi, Devan Jaganath, et al.
Research Square|August 6, 2025
Multicohort assessment of plasma metabolic signatures of tuberculosis disease in childrenMary M Nellis, Juaneta Luiz, Devan Jaganath, et al.
Aging Cell|September 18, 2022
Reduced endosomal microautophagy activity in aging associates with enhanced exocyst-mediated protein secretionGregory J Krause, Antonio Diaz, Maryam Jafari, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Mbio|February 27, 2024
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cellsUjjwal Rathore, Paige Haas, Vigneshwari Easwar Kumar, et al.
The Journal of Clinical Investigation|November 15, 2021
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinomaNan Jin, Bhumsuk Keam, Janice Cho, et al.
Pageof 15